Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA: A Meta-Analysis
Stroke 39:1358-1363, Verro,P.,et al, 2008
Dipyridamole for Preventing Stroke and Other Vascular Events in Patients With Vascular Disease: An Update
Stroke 39:1397-1398, De Schryver,E.L.L.M.,et al, 2008
Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol 56:1087-1092, Wilterdink,J.L.&Easton,J.D., 1999
The European Stroke Prevention Study:Results According to Sex
Neurol 41:1189-1192, Sivenius,J.,et al, 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
The European Stroke Prevention Study (ESPS) Principal End-Points
The ESPS Group, Lancet 2:1351-13541987., , 1987
"AICLA"Controlled Trial of Aspirin & Dipyridamole in the Prevention of Athero-Thrombotic Cerebral Ischemia
Stroke 14:5-14, Bousser,M.G.,et al, 1983
Therapy of Ischemic Cerebrovascular Disease
Ann Int Med 93:742-756, Byer,J.A.,et al, 1980
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975